Skip to Main Content
Contribute Try STAT+ Today

WASHINGTON — Dr. Scott Gottlieb is headed back to the Food and Drug Administration.

By a vote of 57 to 42, the Senate on Tuesday confirmed Gottlieb, a former FDA deputy commissioner, as the agency’s next chief.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • For a decade FDA Commissioners continue to acknowledge the 1000+ studies, especially ongoing NIEHS published studies all confirming adverse fetal, infant, and child body & brain effects are caused by exposure to soy hormone disruptors plus additional developmental soy poisons, i.e.- phytic acid, enzyme inhibitors, heavy metals…etc., and NONE of our FDA Commissioners have yet to lawfully disclose as critical public health information! NIH Collins is also aware of these mass Pubmed studies, as well as multiple FDA testimonials ALL confirming soy phyto-poisons can adversely contaminate physiological, reproductive, and neurological DNA development. NIH and FDA leaders choose to protect overwhelming U.S. marketing of soy plant-poisons in baby formulas and child foods without fair & lawful public disclosure! Unthinkable betrayal! Will FDA Commissioner Scott Gottlieb become an exception? Will Dr. Gottlieb be true to his promise of ethics and good heath…and abide by U.S. public health laws? Ask him.

  • It seems like every nominee has conflicts of interest that require self-induced recusal. Who is going to hold him accountable when he has glaring conflicts with “plausible deniability”? This is getting beyond absurd. In addition, the trump administration already wants to cut what is already severely underfunded, not to mention the promise of weakening the FDA’s regulatory apparatus.

Comments are closed.